Spectrum Pharmaceuticals (SPPI +1.75%) catches an upgrade from hold to buy from TheStreet...

|About: Spectrum Pharmaceuticals,... (SPPI)|By:, SA News Editor

Spectrum Pharmaceuticals (SPPI +1.75%) catches an upgrade from hold to buy from TheStreet Ratings, which cites strengths "in multiple areas." These include "robust revenue growth, a largely solid financial position with reasonable debt levels by most measures, a notable return on equity, attractive valuation levels and expanding profit margins."